When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Among many non-alcoholic steatohepatitis (NASH) drug innovators, Madrigal Pharmaceuticals is poised to deliver the first medicine to the market sometime next year.
By Q4 this year, the company is anticipated to report data for the Phase 3 (MAESTRO-NASH) trial.
Despite strong fundamentals, the shares are trading at a deep bargain to their intrinsic value.